搜索临床试验以:K-877-ER(剂量 B)
总计434个结果
-
Bristol-Myers SquibbCardioxyl Pharmaceuticals, Inc完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
University Hospital MuensterIsotope Technologies Munich (ITM) Oncologics; Helmholtz Zentrum München Deutsches Forschungszentrum...招聘中
-
Forest LaboratoriesIronwood Pharmaceuticals, Inc.完全的
-
Canadian Immunization Research NetworkGlaxoSmithKline; Dalhousie University; MCM Vaccines B.V.; Canadian Center for Vaccinology完全的
-
Beth Israel Medical CenterRiverside Research Institute完全的Clinical Stage T2b or Less of Prostate Cancer | Prostate Brachytherapy | Transrectal Prostate Ultrasound Treatment Planning美国
-
Idorsia Pharmaceuticals Ltd.完全的
-
National Cancer Institute (NCI)主动,不招人解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 转移性三阴性乳腺癌 | 不可切除的三阴性乳腺癌美国
-
MedDay Pharmaceuticals SA完全的Charcot-Marie-Tooth病 | 周围神经病变 | 慢性炎症性脱髓鞘性多发性神经病 | Charcot-Marie-Tooth 病 1A 型 | Charcot-Marie-Tooth 病,1B 型 | 抗 MAG 神经病法国
-
Merck Sharp & Dohme LLC完全的
-
MedDay Pharmaceuticals SA终止多发性硬化症美国, 西班牙, 加拿大, 澳大利亚, 英国, 比利时, 火鸡, 捷克语, 波兰, 意大利, 匈牙利, 德国, 瑞典
-
The Lymphoma Academic Research OrganisationFrench Innovative Leukemia Organisation完全的
-
PhaseBio Pharmaceuticals Inc.完全的
-
National Cardiovascular Center Harapan Kita Hospital...未知
-
Alzheimer's Disease Cooperative Study (ADCS)National Institute on Aging (NIA); Burke Medical Research Institute招聘中
-
Health DecisionsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)未知
-
Merck Sharp & Dohme LLC完全的
-
Tyra Biosciences, Inc招聘中
-
Antengene Therapeutics Limited终止